Nihon Kohden Corporation (OTCMKTS:NHNKY – Get Free Report) was the recipient of a large drop in short interest during the month of July. As of July 15th, there was short interest totaling 6,349 shares, a drop of 55.6% from the June 30th total of 14,284 shares. Based on an average daily trading volume, of 45,861 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the company’s shares are short sold.
Nihon Kohden Trading Up 2.2%
NHNKY stock traded up $0.21 during trading on Wednesday, reaching $10.07. The stock had a trading volume of 12,551 shares, compared to its average volume of 28,321. The company has a market capitalization of $1.69 billion, a P/E ratio of 17.08 and a beta of 0.39. Nihon Kohden has a 1-year low of $8.12 and a 1-year high of $14.21. The firm has a fifty day moving average price of $9.04 and a 200 day moving average price of $9.85.
Nihon Kohden (OTCMKTS:NHNKY – Get Free Report) last posted its quarterly earnings data on Thursday, May 14th. The company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.24 by $0.10. Nihon Kohden had a return on equity of 9.46% and a net margin of 6.08%.The company had revenue of $453.10 million for the quarter, compared to the consensus estimate of $414.40 million. Sell-side analysts predict that Nihon Kohden will post 0.6 EPS for the current year.
Wall Street Analysts Forecast Growth
Check Out Our Latest Stock Report on Nihon Kohden
About Nihon Kohden
Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.
The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.
See Also
- Five stocks we like better than Nihon Kohden
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
- Meta’s AI Spending Problem Just Found a BlackRock Solution
- Broadcom’s $200 Billion Samsung Deal Shows How Costly the AI Memory Race Has Become
- 3 Refiners Benefiting From Oil Volatility and Tight Fuel Supply
Receive News & Ratings for Nihon Kohden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nihon Kohden and related companies with MarketBeat.com's FREE daily email newsletter.
